{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,7,3]],"date-time":"2026-07-03T01:13:10Z","timestamp":1783041190114,"version":"3.54.6"},"reference-count":33,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2018,10,1]],"date-time":"2018-10-01T00:00:00Z","timestamp":1538352000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["81630093"],"award-info":[{"award-number":["81630093"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"name":"Focus on Research and Development Plan","award":["2017CXGC1403"],"award-info":[{"award-number":["2017CXGC1403"]}]},{"name":"Focus on research and development plan","award":["2018GSF118213"],"award-info":[{"award-number":["2018GSF118213"]}]},{"name":"National Science and Technology Project of China","award":["2018ZX09301042-002"],"award-info":[{"award-number":["2018ZX09301042-002"]}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Medicinal Chemistry"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1016\/j.ejmech.2018.09.028","type":"journal-article","created":{"date-parts":[[2018,9,15]],"date-time":"2018-09-15T23:12:06Z","timestamp":1537053126000},"page":"767-780","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":19,"special_numbering":"C","title":["Discovery of furyl\/thienyl \u03b2-carboline derivatives as potent and selective PDE5 inhibitors with excellent vasorelaxant effect"],"prefix":"10.1016","volume":"158","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5628-5277","authenticated-orcid":false,"given":"Hongbo","family":"Zheng","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yifeng","family":"Wu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bin","family":"Sun","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chuanle","family":"Cheng","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yanan","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuehua","family":"Jiang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shengtian","family":"Zhao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zhiyu","family":"Xie","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jing","family":"Tan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3300-1811","authenticated-orcid":false,"given":"Hongxiang","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejmech.2018.09.028_bib1","doi-asserted-by":"crossref","first-page":"174","DOI":"10.1016\/S0955-0674(99)00073-3","article-title":"Regulation of cAMP and cGMP signaling: new phosphodiesterases and new functions","volume":"12","author":"Soderling","year":"2000","journal-title":"Curr. Opin. Cell Biol."},{"key":"10.1016\/j.ejmech.2018.09.028_bib2","doi-asserted-by":"crossref","first-page":"801","DOI":"10.3390\/ijms19030801","article-title":"cGMP signaling in the cardiovascular system-the role of compartmentation and its live cell imaging","volume":"19","author":"Bork","year":"2018","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.ejmech.2018.09.028_bib3","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1016\/j.ejmech.2015.12.002","article-title":"Discovery and modelling studies of natural ingredients from Gaultheria yunnanensis (FRANCH.) against phosphodiesterase-4","volume":"114","author":"Cai","year":"2016","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.028_bib4","doi-asserted-by":"crossref","first-page":"515","DOI":"10.1016\/j.ejphar.2013.06.035","article-title":"Neuroprotective role of PDE4 and PDE5 inhibitors in 3-nitropropionic acid induced behavioral and biochemical toxicities in rats","volume":"714","author":"Thakur","year":"2013","journal-title":"Eur. J. Pharmacol."},{"key":"10.1016\/j.ejmech.2018.09.028_bib5","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1016\/j.ejmech.2012.12.009","article-title":"Synthesis of quinoline derivatives: discovery of a potent and selective phosphodiesterase 5 inhibitor for the treatment of Alzheimer's disease","volume":"60","author":"Fiorito","year":"2013","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.028_bib6","doi-asserted-by":"crossref","first-page":"5467","DOI":"10.1021\/acs.jmedchem.7b01370","article-title":"Novel phosphodiesterase inhibitors for cognitive improvement in alzheimer's disease","volume":"61","author":"Wu","year":"2018","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.028_bib7","doi-asserted-by":"crossref","first-page":"654","DOI":"10.1124\/jpet.105.092544","article-title":"Differential effects of the phosphodiesterase type 5 inhibitors sildenafil, vardenafil, and tadalafil in rat aorta","volume":"316","author":"Teixeira","year":"2006","journal-title":"J.\u00a0Pharmacol. Exp. Therapeut."},{"key":"10.1016\/j.ejmech.2018.09.028_bib8","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.ejmech.2018.03.046","article-title":"Inhibitors of phosphodiesterase as cancer therapeutics","volume":"150","author":"Peng","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.028_bib9","doi-asserted-by":"crossref","first-page":"290","DOI":"10.1038\/nrd4228","article-title":"Advances in targeting cyclic nucleotide phosphodiesterases","volume":"13","author":"Maurice","year":"2014","journal-title":"Nat. Rev. Drug Discov."},{"key":"10.1016\/j.ejmech.2018.09.028_bib10","doi-asserted-by":"crossref","first-page":"533","DOI":"10.1038\/sj.ijir.3901577","article-title":"PDE5 inhibitors beyond erectile dysfunction","volume":"19","author":"Sandner","year":"2007","journal-title":"Int. J. Impot. Res."},{"key":"10.1016\/j.ejmech.2018.09.028_bib11","doi-asserted-by":"crossref","first-page":"548","DOI":"10.1016\/j.ejmech.2017.03.091","article-title":"Synthesis and in\u00a0vitro evaluation of new fluorinated quinoline derivatives with high affinity for PDE5: towards the development of new PET neuroimaging probes","volume":"136","author":"Liu","year":"2017","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.028_bib12","doi-asserted-by":"crossref","first-page":"457","DOI":"10.1021\/jm0256068","article-title":"Substituted pyrazolopyridopyridazines as orally bioavailable potent and selective PDE5 Inhibitors:\u2009 potential agents for treatment of erectile dysfunction","volume":"46","author":"Yu","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.028_bib13","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1016\/S0960-894X(02)00030-6","article-title":"Imidazo[5,1-f]triazin-4(3H)-ones, a new class of potent PDE 5 inhibitors","volume":"12","author":"Haning","year":"2002","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.09.028_bib14","doi-asserted-by":"crossref","first-page":"4533","DOI":"10.1021\/jm0300577","article-title":"The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 2: 2,3,6,7,12,12a-hexahydropyrazino[1',2':1,6]pyrido[3,4-b]indole-1,4-dione analogues","volume":"46","author":"Daugan","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.028_bib15","first-page":"668","article-title":"Avanafil, a potent and highly selective phosphodiesterase-5 inhibitor for erectile dysfunction","volume":"188","author":"Kotera","year":"2012","journal-title":"J.\u00a0Urol."},{"key":"10.1016\/j.ejmech.2018.09.028_bib16","doi-asserted-by":"crossref","first-page":"4094","DOI":"10.1021\/jm025545d","article-title":"Pyrimidinylpyrroloquinolones as highly potent and selective PDE5 inhibitors for treatment of erectile dysfunction","volume":"45","author":"Sui","year":"2002","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.028_bib17","doi-asserted-by":"crossref","first-page":"4525","DOI":"10.1021\/jm030056e","article-title":"The discovery of tadalafil: a novel and highly selective PDE5 inhibitor. 1: 5,6,11,11a-tetrahydro-1H-imidazo[1',5':1,6]pyrido[3,4-b]indole-1,3(2H)-dione analogues","volume":"46","author":"Daugan","year":"2003","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.028_bib18","doi-asserted-by":"crossref","first-page":"761","DOI":"10.1016\/S0960-894X(02)01036-3","article-title":"Synthesis and biological activities of novel \u03b2-Carbolines as PDE5 inhibitors","volume":"13","author":"Sui","year":"2003","journal-title":"Bioorg. Med. Chem. Lett"},{"key":"10.1016\/j.ejmech.2018.09.028_bib19","doi-asserted-by":"crossref","first-page":"273","DOI":"10.1071\/CH03230","article-title":"A\u00a0revised structure for the alkaloid, tribulusterine, from Tribulus Terrestris L.","volume":"57","author":"Bremner","year":"2004","journal-title":"Aust. J. Chem."},{"key":"10.1016\/j.ejmech.2018.09.028_bib20","doi-asserted-by":"crossref","first-page":"30","DOI":"10.1016\/j.ejmech.2018.02.039","article-title":"Design and synthesis of furyl\/thineyl pyrroloquinolones based on natural alkaloid perlolyrine, lead to the discovery of potent and selective PDE5 inhibitors","volume":"150","author":"Zheng","year":"2018","journal-title":"Eur. J. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.028_bib21","doi-asserted-by":"crossref","first-page":"23","DOI":"10.1002\/ardp.201200334","article-title":"Design of novel \u03b2-carboline derivatives with pendant 5-bromothienyl and their evaluation as phosphodiesterase-5 inhibitors","volume":"346","author":"El-Gamil","year":"2013","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2018.09.028_bib22","doi-asserted-by":"crossref","DOI":"10.1002\/ardp.201800018","article-title":"Design and synthesis of novel annulated thienopyrimidines as phosphodiesterase 5 (PDE5) inhibitors","volume":"351","author":"El-Sharkawy","year":"2018","journal-title":"Arch. Pharmazie"},{"key":"10.1016\/j.ejmech.2018.09.028_bib23","doi-asserted-by":"crossref","first-page":"6622","DOI":"10.1021\/acs.jmedchem.7b00523","article-title":"Discovery and optimization of chromeno[2,3-c]pyrrol-9(2H)-ones as novel selective and orally bioavailable phosphodiesterase 5 inhibitors for the treatment of pulmonary arterial hypertension","volume":"60","author":"Wu","year":"2017","journal-title":"J.\u00a0Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.028_bib24","doi-asserted-by":"crossref","first-page":"730","DOI":"10.3109\/14756366.2011.611136","article-title":"Docking-based CoMFA and CoMSIA analyses of tetrahydro-\u03b2-carboline derivatives as type-5 phosphodiesterase inhibitors","volume":"27","author":"Cichero","year":"2012","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.028_bib25","doi-asserted-by":"crossref","first-page":"2233","DOI":"10.1016\/j.str.2004.10.004","article-title":"Structural basis for the activity of drugs that inhibit phosphodiesterases","volume":"12","author":"Card","year":"2004","journal-title":"Structure"},{"key":"10.1016\/j.ejmech.2018.09.028_bib26","doi-asserted-by":"crossref","first-page":"311","DOI":"10.1080\/14756366.2016.1250756","article-title":"Investigation of PDE5\/PDE6 and PDE5\/PDE11 selective potent tadalafil-like PDE5 inhibitors using combination of molecular modeling approaches, molecular fingerprint-based virtual screening protocols and structure-based pharmacophore development","volume":"32","author":"Kay\u0131k","year":"2017","journal-title":"J.\u00a0Enzym. Inhib. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.028_bib27","doi-asserted-by":"crossref","first-page":"3044","DOI":"10.1021\/ci400458z","article-title":"The molecular basis for the selectivity of tadalafil toward phosphodiesterase 5 and 6: a modeling study","volume":"53","author":"Huang","year":"2013","journal-title":"J.\u00a0Chem. Inf. Model."},{"key":"10.1016\/j.ejmech.2018.09.028_bib28","doi-asserted-by":"crossref","first-page":"6012","DOI":"10.1002\/anie.201500703","article-title":"Organocatalytic enantioselective oxidative C-H alkenylation and arylation of N-carbamoyl tetrahydropyridines and tetrahydro-\u03b2-carbolines","volume":"54","author":"Liu","year":"2015","journal-title":"Angew. Chem. Int. Ed."},{"key":"10.1016\/j.ejmech.2018.09.028_bib29","article-title":"Assessing murine resistance artery function using pressure myography","volume":"76","author":"Shahid","year":"2013","journal-title":"J.\u00a0Vis. Exp. Jove"},{"key":"10.1016\/j.ejmech.2018.09.028_bib30","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1038\/aps.2017.120","article-title":"Rhynchophylla total alkaloid rescues autophagy, decreases oxidative stress and improves endothelial vasodilation in spontaneous hypertensive rats","volume":"39","author":"Li","year":"2018","journal-title":"Acta Pharmacol. Sin."},{"key":"10.1016\/j.ejmech.2018.09.028_bib31","doi-asserted-by":"crossref","first-page":"4320","DOI":"10.1016\/j.bmc.2018.07.035","article-title":"Terpenoids with vasorelaxant effects from the Chinese liverwort Scapania carinthiaca","volume":"26","author":"Qiao","year":"2018","journal-title":"Bioorg. Med. Chem."},{"key":"10.1016\/j.ejmech.2018.09.028_bib32","doi-asserted-by":"crossref","first-page":"215","DOI":"10.1177\/108705710200700305","article-title":"A\u00a0fluorescence polarization assay for cyclic nucleotide phosphodiesterases","volume":"7","author":"Huang","year":"2002","journal-title":"J.\u00a0Biomol. Screen"},{"key":"10.1016\/j.ejmech.2018.09.028_bib33","doi-asserted-by":"crossref","first-page":"484","DOI":"10.1016\/j.ejmech.2016.06.007","article-title":"Design, synthesis and biological evaluation of novel macrocyclic bisbibenzyl analogues as tubulin polymerization inhibitors","volume":"121","author":"Sun","year":"2016","journal-title":"Eur. J. Med. Chem."}],"container-title":["European Journal of Medicinal Chemistry"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418308006?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0223523418308006?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2018,10,6]],"date-time":"2018-10-06T02:06:59Z","timestamp":1538791619000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0223523418308006"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,10]]},"references-count":33,"alternative-id":["S0223523418308006"],"URL":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.09.028","relation":{},"ISSN":["0223-5234"],"issn-type":[{"value":"0223-5234","type":"print"}],"subject":[],"published":{"date-parts":[[2018,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Discovery of furyl\/thienyl \u03b2-carboline derivatives as potent and selective PDE5 inhibitors with excellent vasorelaxant effect","name":"articletitle","label":"Article Title"},{"value":"European Journal of Medicinal Chemistry","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejmech.2018.09.028","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2018 Elsevier Masson SAS. All rights reserved.","name":"copyright","label":"Copyright"}]}}